Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00779402 | PROvenge Treatment and Early Cancer Treatment(PROTECT) | completed | Phase 3 | 176 | DendreonINDUSTRY | 1 | Jan 29, 2018 | clinicaltrials |
| NCT01105338 | Lycopene or Green Tea for Men at Risk of Prostate Cancer(ProDiet) | completed | Phase 2 / Phase 3 | 126 | University of BristolOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT03406169 | Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy | unknown | Phase 3 | 180 | Brooke Army Medical CenterFED | 1 | Jan 23, 2018 | clinicaltrials |
| NCT00329797 | Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy | completed | Phase 3 | 109 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 29, 2017 | clinicaltrials |
| NCT03344822 | Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients(TePSMAG-68) | unknown | Phase 2 / Phase 3 | 33 | Central Hospital, Nancy, FranceOTHER | 1 | Nov 17, 2017 | clinicaltrials |
| NCT00142506 | Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer | completed | Phase 3 | 290 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 20, 2017 | clinicaltrials |
| NCT00193856 | RADAR Trial - Randomised Androgen Deprivation and Radiotherapy | completed | Phase 3 | 1,071 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Oct 12, 2017 | clinicaltrials |
| NCT01613651 | Robotic Assisted Laparoscopic Prostatectomy With or Without Pelvic Drain Placement in Reducing Adverse Events After Surgery in Patients With Prostate Cancer | completed | Phase 3 | 191 | City of Hope Medical CenterOTHER | 1 | Sep 14, 2017 | clinicaltrials |
| NCT00304759 | PROFIT - Prostate Fractionated Irradiation Trial | completed | Phase 3 | 1,204 | Ontario Clinical Oncology Group (OCOG)OTHER | 3 | Jul 31, 2017 | clinicaltrials |
| NCT02526784 | A Trial Evaluating Two Subcutaneous Injection Techniques and Intramuscular Administration of Degarelix in Patients With Prostate Cancer | completed | Phase 3 | 120 | Ferring PharmaceuticalsINDUSTRY | 3 | Jul 5, 2017 | clinicaltrials |
| NCT00925600 | Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss | completed | Phase 3 | 769 | AmgenINDUSTRY | 18 | May 30, 2017 | clinicaltrials |
| NCT01193244 | Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer | completed | Phase 3 | 1,560 | Millennium Pharmaceuticals, Inc.INDUSTRY | 40 | May 17, 2017 | clinicaltrials |
| NCT00060476 | Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201) | completed | Phase 3 | 15,000 | Merck Sharp & Dohme LLCINDUSTRY | 0 | May 9, 2017 | clinicaltrials |
| NCT00509444 | Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial(CPTD) | completed | Phase 3 | 200 | Johns Hopkins Bloomberg School of Public HealthOTHER | 1 | Apr 20, 2017 | clinicaltrials |
| NCT02016040 | Focal Therapy Using HIFU for Localised Prostate Cancer | unknown | Phase 2 / Phase 3 | 25 | Jewish General HospitalOTHER | 1 | Apr 19, 2017 | clinicaltrials |
| NCT00002651 | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | completed | Phase 3 | 3,040 | SWOG Cancer Research NetworkNETWORK | 1 | Apr 17, 2017 | clinicaltrials |
| NCT01308580 | Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer(PROSELICA) | completed | Phase 3 | 1,200 | SanofiINDUSTRY | 22 | Apr 17, 2017 | clinicaltrials |
| NCT01415960 | Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer | completed | Phase 3 | 163 | GP-PharmINDUSTRY | 1 | Mar 3, 2017 | clinicaltrials |
| NCT00171639 | The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis | completed | Phase 3 | 28 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00769548 | Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer | completed | Phase 3 | 1,322 | Radiation Therapy Oncology GroupNETWORK | 0 | Jan 4, 2017 | clinicaltrials |
| NCT00928434 | A Study of Degarelix in Patients With Prostate Cancer | completed | Phase 3 | 409 | Ferring PharmaceuticalsINDUSTRY | 1 | Dec 13, 2016 | clinicaltrials |
| NCT00043069 | Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer | completed | Phase 3 | 71 | Alliance for Clinical Trials in OncologyOTHER | 2 | Dec 7, 2016 | clinicaltrials |
| NCT02934685 | IG-VMAT for Localized Prostate Cancer | unknown | Phase 3 | 60 | Beijing HospitalOTHER_GOV | 1 | Nov 18, 2016 | clinicaltrials |
| NCT02265159 | Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound for the Treatment of Prostate Cancer | unknown | Phase 2 / Phase 3 | 100 | University of ZurichOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT00553878 | Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer(AVIAS) | completed | Phase 2 / Phase 3 | 100 | Canadian Urology Research ConsortiumOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT01188187 | Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer(SYNERGY) | completed | Phase 3 | 1,022 | Achieve Life SciencesINDUSTRY | 12 | Oct 14, 2016 | clinicaltrials |
| NCT01354171 | Active Surveillance Magnetic Resonance Imaging Study(ASIST) | unknown | Phase 3 | 250 | Canadian Urology Research ConsortiumOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT01578655 | Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer(AFFINITY) | completed | Phase 3 | 630 | Achieve Life SciencesINDUSTRY | 8 | Oct 12, 2016 | clinicaltrials |
| NCT00861614 | Study of Immunotherapy to Treat Advanced Prostate Cancer | completed | Phase 3 | 988 | Bristol-Myers SquibbINDUSTRY | 27 | Sep 30, 2016 | clinicaltrials |
| NCT00138008 | Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy | completed | Phase 3 | 200 | Haruhiko FukudaOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT02367404 | Prospective RCT on Post Prostatectomy Urine Leak | unknown | Phase 3 | 240 | Institut Mutualiste MontsourisOTHER | 1 | Sep 13, 2016 | clinicaltrials |
| NCT00021450 | Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer | completed | Phase 3 | 819 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Sep 2, 2016 | clinicaltrials |
| NCT01057810 | Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer | completed | Phase 3 | 837 | Bristol-Myers SquibbINDUSTRY | 24 | Aug 18, 2016 | clinicaltrials |
| NCT00691899 | A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030) | withdrawn | Phase 3 | 0 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 12, 2016 | clinicaltrials |
| NCT00003734 | Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer | unknown | Phase 3 | 276 | St. Luke's Hospital, IrelandOTHER | 2 | Jul 21, 2016 | clinicaltrials |
| NCT00003674 | Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer | completed | Phase 3 | 141 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT00033605 | Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | completed | Phase 3 | 130 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 13, 2016 | clinicaltrials |
| NCT00439751 | Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy(ELAAT) | completed | Phase 3 | 79 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jul 12, 2016 | clinicaltrials |
| NCT00023686 | Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer | completed | Phase 3 | 190 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 6, 2016 | clinicaltrials |
| NCT00002760 | Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer | completed | Phase 3 | 260 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 28, 2016 | clinicaltrials |
| NCT00028574 | Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer | completed | Phase 3 | 223 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 28, 2016 | clinicaltrials |
| NCT00003607 | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer | completed | Phase 3 | 450 | UNICANCEROTHER | 1 | Jun 23, 2016 | clinicaltrials |
| NCT00003682 | Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer | terminated | Phase 3 | 160 | UNICANCEROTHER | 1 | Jun 23, 2016 | clinicaltrials |
| NCT00216060 | Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy | terminated | Phase 3 | 63 | Christopher Sweeney, MBBSOTHER | 2 | May 26, 2016 | clinicaltrials |
| NCT01978873 | Efficacy Study Evaluating Chemotherapy in Prostate Cancer(SensiCab) | unknown | Phase 3 | 400 | Örebro University, SwedenOTHER | 1 | May 4, 2016 | clinicaltrials |
| NCT01981707 | F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer(PRECHOL) | terminated | Phase 2 / Phase 3 | 12 | University Hospital, GrenobleOTHER | 1 | Apr 28, 2016 | clinicaltrials |
| NCT01875393 | Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer(PCM304) | completed | Phase 3 | 81 | Steba Biotech S.A.OTHER | 3 | Apr 19, 2016 | clinicaltrials |
| NCT00243646 | Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial | terminated | Phase 3 | 6 | Schiffler Cancer CenterOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT00024167 | Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer | terminated | Phase 3 | 265 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT01603420 | External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer | terminated | Phase 2 / Phase 3 | 2 | Proton Collaborative GroupNETWORK | 1 | Mar 14, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Jan 29, 2018source: clinicaltrials